An observational study suggests that adding coronary artery calcium results to traditional risk models yields synergistic value and the promise of a precision medicine approach.
Read MoreTargeting Inflammation Is Best Way to Reduce Residual Risk in Statin-Treated Patients, Study Suggests
Vascular inflammation is a stronger predictor of residual cardiovascular risk than LDL cholesterol level among statin-treated patients. This finding from a large analysis of contemporary trials points to a potential new standard of care for atherosclerosis.
CLEAR Outcomes: Bempedoic Acid Reduces Cardiovascular Events in Statin-Intolerant Patients
A 14,000-patient trial has shown that LDL cholesterol reduction with the non-statin therapy translates to a lower rate of cardiovascular death, heart attack, stroke or revascularization.
Sugar Substitute Erythritol Linked to Increased Cardiovascular Risk
A new series of studies provides the strongest evidence to date of cardiovascular risk associated with an artificial sweetener. The researchers call for revisiting food labeling requirements and more safety studies of sugar substitutes.
ChatGPT Performs ‘Better Than Expected’ in Responding to Basic Cardiology Queries
The artificial intelligence model appropriately answered a large majority of common patient questions about heart health in a preliminary study. But many questions remain before clinical use is a possibility.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Menopausal Hormone Therapy and Heart Risk: Updated Guidance Is at Hand
A new review by an American College of Cardiology working group urges a nuanced approach in counseling women about the benefits and risks of hormone therapy from a cardiology perspective.
New Weight-Loss Drugs Are Poised to Upend Preventive Cardiology Care in Patients With Obesity and Overweight
Randomized trial evidence that weight loss can yield cardiovascular benefits independent of antidiabetic effects has been elusive. Two major ongoing trials are likely to change that, with potentially big implications for clinical practice.
Statins Reduce Circulating TMAO, Suggesting Another Way They Curb Cardiovascular Risk
A new study suggests that plasma levels of this gut microbial metabolite might help further stratify cardiovascular risk when characterizing patients’ response to statin therapy.
New Vaccination Process is a Shot in the Arm for Patient Safety
Determined to promote safety and improve the confidence of clinicians who provide vaccines, a team of pediatric nurses has developed a new protocol to streamline the administration of immunizations.
Dietary Supplements Don’t Stack Up to Low-Dose Statin Therapy for LDL-C Reduction
Despite marketing claims, none of six dietary supplements commonly used for lipid lowering significantly reduced LDL cholesterol versus placebo adults with elevated atherosclerotic risk, a new study finds.
Research Highlights Link Between Food Insecurity, Neighborhood Disadvantage and Healthcare Utilization
A Cleveland Clinic nurse scientist examined the relationship between food insecurity, neighborhood disadvantage and healthcare utilization. Based on the findings, she offers advice on screening patients and connecting them with community resources.